CTRI/2024/02/062896尚未招募不适用
Study of clinical outcome of cirrhotic patients admitted with an episode of acute decompensation
Govind Ballabh Pant Institute of Post Graduate Medical Education and Research1 个研究点 分布在 1 个国家目标入组 105 人开始时间: 2024年3月1日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 105
- 试验地点
- 1
- 主要终点
- The proportion of Pre-ACLF, UDC (unstable decompensated cirrhotic), SDC (stable decompensated cirrhotic) in cirrhotic patients who are admitted with an episode of Acute decompensation.
研究概览
简要总结
I will be doing observational study in cirrhotic patients of any etiology who are admitted with acute decompensation and will follow up those patients till 3 months by biochemical markers. So that we can predict the patients, that are going to have ACLF or Unstable Decompensated cirrhosis or Stable decompensated Cirrhosis on follow up, So we can treat them accordingly at their acute decompensation.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •Diagnosed cases of chronic liver disease presenting with acute Decompensation with or without prior Decompensation.
排除标准
- •Acquired or inherited immunodeficiency
- •Prior liver transplant
- •On any immunosuppressive therapy
- •Acute on chronic liver failure
- •Confirmed pregnancy
- •Patient with life-threatening chronic condition like uncontrolled diabetes mellitus, acute Decompensated heart failure, end stage renal disease, severe COPD.
- •Diagnosed case of Hepatocellular carcinoma
- •Extra-hepatic malignancy.
结局指标
主要结局
The proportion of Pre-ACLF, UDC (unstable decompensated cirrhotic), SDC (stable decompensated cirrhotic) in cirrhotic patients who are admitted with an episode of Acute decompensation.
时间窗: Patients will be followed at following intervals - At admission, At 2 weeks, At 1 month, At 2nd month, At 3rd month
次要结局
- The clinical & biochemical predictors of mortality & development of ACLF during the follow-up period.(The clinical & biochemical predictors of development of stable decompensated cirrhotic during the follow-up period.)
研究者
Dr KAPIL KUMAR
Delhi university
研究点 (1)
Loading locations...
相似试验
尚未招募
4 期
Randomized controlled trial comparing the efficacy of Furosemide vs Torsemide in cirrhotic patients with newly diagnosed ascitesCTRI/2024/05/067631Amrita school of Medicine100
已完成
不适用
Mortality predictor in Acute on Chronic liver failureCTRI/2024/03/063706Amar Minda60
尚未招募
4 期
COMPARISON OF MIDODRINE+STANDARD MEDICAL THERAPY AND STANDARD MEDICAL THERAPY ALONE IN CIRRHOSIS ASSOCIATED REFRACTORY ASCITES PATIENTSCTRI/2024/04/065206Amrita School of Medicine80
尚未招募
Unknown
It is study on what happens to patients with liver disease who are hospitalized because their condition suddenly worsens.CTRI/2024/02/062896Govind Ballabh Pant Institute of Post Graduate Medical Education and Research
已完成
3 期
An ayurvedic management of Jalodara-ascitesCTRI/2024/03/064268J S ayurved mahavidyalaya30